Case Report: Immune checkpoint inhibitor-induced myositis without elevated creatine kinase
Immune checkpoint inhibitors (ICIs) have revolutionized the treatment of advanced cancers like malignant melanoma. However, they can lead to a range of immune-related adverse events (irAEs), impacting various organ systems. Among these, myositis is a rare but serious irAE, typically characterized by...
Saved in:
| Main Authors: | Klajdi Begaj, Raphael Wilhelm, Alisa Lepper, Maike Kaufhold, Jakob Veeser, Stephan Grabbe, Henner Stege |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2025-06-01
|
| Series: | Frontiers in Immunology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fimmu.2025.1592385/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Myositis in Scrub Typhus: Atypical Presentation
by: Parth Sharma, et al.
Published: (2025-07-01) -
Efgartigimod therapy for immune checkpoint inhibitor–associated myasthenia gravis with myositis: a case report
by: Feiteng Qi, et al.
Published: (2025-07-01) -
Myositis-specific and myositis-associated autoantibodies: their clinical characteristics and potential pathogenic roles
by: Mariko Ogawa-Momohara, et al.
Published: (2025-04-01) -
Incidence and Immunopathology of Myositis in Rectal Cancer Patients Treated With Neoadjuvant Immune Checkpoint Inhibitors and Chemoradiotherapy: Findings From the CHINOREC Trial
by: Rebecca Zirnbauer, et al.
Published: (2025-07-01) -
A review of immune checkpoint inhibitor-associated myocarditis: Epidemiology, pathogenesis, and biomarkers
by: Le Xu, et al.
Published: (2025-12-01)